SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Feathered Propeller who wrote (1180)6/12/1999 1:59:00 PM
From: Glenn Petersen  Read Replies (1) | Respond to of 1754
 
The article was from March 2, 1999, prior to VISX's 2 for 1 stock split. Adjusting for the split, Warburg's 1999 price target would be $55. Hopefully, they have since upped that target.



To: Feathered Propeller who wrote (1180)6/20/1999 11:43:00 PM
From: stan roberts  Read Replies (1) | Respond to of 1754
 
Is VISX overpriced at $72/shr? VISX Inc. is this weeks WSRN's "Company of the Week" pick. A base case scenario is set up for evaluation for this week only, in "The Value Point Analysis Financial Forum" site at eduvest.com.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News